Emerging Agents in the Pipeline for Merkel Cell Carcinoma
2 ビュー
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
もっと見せる
フェイスブックのコメント
コメントがありません